Study of Vranashodhak Lepa For the Management Of Infected wound

Randomized Open Controlled Clinical Study On The Role Of Vranashodhak Lepa In The Management Of Dushtavrana with special Reference To Infected Wound

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043080

Enrollment

Registered

2022-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L768- Other intraoperative and postprocedural complications of skin and subcutaneous tissue Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 3: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Vranashodhak Lepa: Local application of vranashodhak Lepa of thickness 1cm for 20 days Intervention2: Vranashodhak Lepa: Local application of vranashodhak lepa of thickness 1cm on alter

Eligibility

Inclusion criteria

Inclusion criteria: Wounds with slough and foul smell Size of wound-lenght and breathe 2to10cm Depth upto 1cm Controlled Diabetic Wounds

Exclusion criteria

Exclusion criteria: Wounds with excessive loss of tissues Tuberculous ulcers Venous ulcers Malignant ulcers Burns Known case of HIV and HBsAg positive patients

Design outcomes

Primary

Measure	Time frame
Slough Smell Pain SwellingTimepoint: For 10 days	—

Secondary

Measure	Time frame
Size of wound Granulation tissueTimepoint: For next 10 days	—

Countries

India

Contacts

Public ContactPratibha uttareshwar surawase

Yashwant Ayurvedic College PGT and RC Kodoli

drsuyog0222@gmail.com07028921994

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026